Financhill
Sell
48

PSTX Quote, Financials, Valuation and Earnings

Last price:
$9.44
Seasonality move :
-14.94%
Day range:
$9.36 - $9.49
52-week range:
$1.87 - $9.58
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
6.07x
P/B ratio:
10.58x
Volume:
2.1M
Avg. volume:
2M
1-year change:
194.1%
Market cap:
$923M
Revenue:
$64.7M
EPS (TTM):
-$0.62

Earnings Data

Next earnings date for PSTX
Mar 07
2025
Most recent earnings per share
$0.21
Beat by $0.63
(Nov 7/2024)
Consensus Estimate
-$0.42
(Nov 7/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

PSTX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/07/2025 Q4 $21.3M -- -- -$0.36 --
11/07/2024 Q3 $16.3M $71.7M $0.21 -$0.42 $0.63
08/05/2024 Q2 $15.4M $26M -$0.32 -$0.43 $0.11
05/14/2024 Q1 $11.7M $28.1M -$0.25 -$0.43 $0.18
03/07/2024 Q4 $7.2M $25M -$0.26 -$0.36 $0.10
11/09/2023 Q3 -- -- -$0.35 -$0.27 -$0.08
08/08/2023 Q2 -- -- -$0.32 -$0.54 $0.22
05/09/2023 Q1 -- -- -$0.45 -$0.42 -$0.03
03/09/2023 Q4 -- -- -$0.39 $0.29 -$0.68
11/09/2022 Q3 -- -- $0.92 -$0.65 $1.57
08/11/2022 Q2 -- -- -$0.69 -$0.76 $0.07
05/12/2022 Q1 -- -- -$0.93 -$0.61 -$0.32
03/10/2022 Q4 -- -- $0.02 -$0.35 $0.37
11/09/2021 Q3 -- -- -$0.68 -$0.75 $0.07
08/12/2021 Q2 -- -- -$0.74 -$0.64 -$0.11
05/11/2021 Q1 -- -- -$0.62 -$0.67 $0.05
03/11/2021 Q4 -- -- -$0.58 -$0.66 $0.08
11/12/2020 Q3 -- -- -$0.63 -$0.52 -$0.12
08/20/2020 Q2 -- -- -$0.53 -$2.11 $1.58
03/31/2020 Q1 -- -- -$0.50 -- --
12/31/2019 Q4 -- -- -$0.59 -- --
09/30/2019 Q3 -- -- -$0.53 -- --
06/30/2019 Q2 -- -- -$0.72 -- --
03/31/2019 Q1 -- -- -$0.34 -- --

Poseida Therapeutics Earnings Questions

  • How Much did Poseida Therapeutics Generate in Revenue Last Quarter?

    Poseida Therapeutics reported $71.7M worth of top line sales in its most recent quarter.

  • Did Poseida Therapeutics Beat Earnings Last Quarter?

    Poseida Therapeutics announced earnings per share of $0.21 which represents a beat of analyst forecast a -$0.42 per share.

  • Is Poseida Therapeutics Profitable?

    Poseida Therapeutics reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Poseida Therapeutics EPS Next Year?

    Poseida Therapeutics's earnings are forecast to decrease from -$1.37 per share to -$1.47 per share next year representing a decrease of -46.96%.

  • When is Poseida Therapeutics's Earnings Date?

    Poseida Therapeutics's next earnings date is March 7, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

NVIDIA vs Broadcom Stock: Which Is Best?
NVIDIA vs Broadcom Stock: Which Is Best?

If you want to invest in an AI-leading tech company,…

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 23

Quantum [QMCO] is up 2.15% over the past day.

Sell
46
NUKK alert for Dec 23

Nukkleus [NUKK] is up 12.5% over the past day.

Sell
1
IIPR alert for Dec 23

Innovative Industrial Properties [IIPR] is down 5.85% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock